ProPhase Labs (PRPH) Expected to Announce Earnings on Wednesday

ProPhase Labs (NASDAQ:PRPH) is expected to issue its Q2 2025 quarterly earnings data before the market opens on Wednesday, August 13th. Analysts expect ProPhase Labs to post earnings of ($0.15) per share and revenue of $3.55 million for the quarter.

ProPhase Labs (NASDAQ:PRPH) last released its quarterly earnings results on Tuesday, May 20th. The company reported ($0.12) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.06. The business had revenue of $1.43 million during the quarter, compared to analysts’ expectations of $2.45 million. On average, analysts expect ProPhase Labs to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

ProPhase Labs Trading Down 4.3%

ProPhase Labs stock opened at $0.31 on Monday. ProPhase Labs has a one year low of $0.22 and a one year high of $3.00. The stock has a market cap of $12.97 million, a PE ratio of -0.25 and a beta of -0.48. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.98 and a current ratio of 1.03. The stock has a 50-day moving average of $0.37 and a two-hundred day moving average of $0.37.

ProPhase Labs Company Profile

ProPhase Labs, Inc develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster.